Last updated: 25 March 2024 at 9:39pm EST

Michael Patrick Donovan Net Worth




The estimated Net Worth of Michael Patrick Donovan is at least $1.85 Milion dollars as of 16 March 2024. Michael Donovan owns over 24,575 units of Axogen stock worth over $781,475 and over the last 9 years Michael sold AXGN stock worth over $1,065,533.

Michael Donovan AXGN stock SEC Form 4 insiders trading

Michael has made over 20 trades of the Axogen stock since 2017, according to the Form 4 filled with the SEC. Most recently Michael exercised 24,575 units of AXGN stock worth $326,356 on 16 March 2024.

The largest trade Michael's ever made was selling 36,310 units of Axogen stock on 7 March 2024 worth over $319,891. On average, Michael trades about 5,857 units every 69 days since 2015. As of 16 March 2024 Michael still owns at least 58,846 units of Axogen stock.

You can see the complete history of Michael Donovan stock trades at the bottom of the page.



What's Michael Donovan's mailing address?

Michael's mailing address filed with the SEC is 13631 Progress Blvd #400, Alachua, FL 32615, USA.

Insiders trading at Axogen

Over the last 13 years, insiders at Axogen have traded over $73,805,978 worth of Axogen stock and bought 504,297 units worth $3,119,117 . The most active insiders traders include James E Deerfield Mgmt L.P...., Guido J Neels a Karen L. Zaderej. On average, Axogen executives and independent directors trade stock every 21 days with the average trade being worth of $455,132. The most recent stock trade was executed by John Johnson on 1 September 2024, trading 11,904 units of AXGN stock currently worth $158,085.



What does Axogen do?

it's time to rethink nerve repair! axogen (nasdaq: axgn) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. people suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. damage may cause loss of function and feeling. axogen is bringing the science of nerve repair to life with its avance® nerve graft which axogen believes is the first and only commercially available allograft for bridging nerve discontinuities, axoguard® nerve connector, a coaptation aid allowing for close approximation of severed nerves, and axoguard® nerve protector that protects nerves during the healing process.



Complete history of Michael Donovan stock trades at Axogen

Osoba
Trans.
Transakce
Celková cena
Michael Patrick Donovan
VP Operations
Využití opce $188,736
16 Mar 2024
Michael Patrick Donovan
VP Operations
Prodej $319,891
7 Mar 2024
Michael Patrick Donovan
VP Operations
Využití opce $73,603
16 Mar 2023
Michael Patrick Donovan
VP Operations
Využití opce $10,856
27 Dec 2022
Michael Patrick Donovan
VP Operations
Využití opce $49,200
16 Mar 2022
Michael Patrick Donovan
VP Operations
Využití opce $78,150
22 Feb 2022
Michael Patrick Donovan
VP Operations
Využití opce $11,201
27 Dec 2021
Michael Patrick Donovan
VP Operations
Využití opce $3,465
20 Dec 2021
Michael Patrick Donovan
VP Operations
Prodej $34,623
18 Feb 2021
Michael Patrick Donovan
VP Operations
Využití opce $102,800
5 Feb 2021
Michael Patrick Donovan
VP Operations
Prodej $30,293
30 Dec 2020
Michael Patrick Donovan
VP Operations
Prodej $10,098
27 Dec 2020
Michael Patrick Donovan
VP Operations
Prodej $4,796
22 Dec 2020
Michael Patrick Donovan
VP Operations
Prodej $1,576
18 Dec 2020
Michael Patrick Donovan
VP Operations
Prodej $264,255
9 Nov 2020
Michael Patrick Donovan
VP Operations
Využití opce $62,400
28 May 2020
Michael Patrick Donovan
VP Operations
Využití opce $28,405
8 Oct 2019
Michael Patrick Donovan
VP Operations
Prodej $400,000
13 Jun 2019
Michael Patrick Donovan
VP Operations
Využití opce $82,200
26 Mar 2018
Michael Patrick Donovan
VP Operations
Využití opce $14,971
14 Mar 2017


Axogen executives and stock owners

Axogen executives and other stock owners filed with the SEC include: